Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service.
Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service.
复制标题
DOI:
10.1007/s12325-021-01833-4
复制
发表时间:
2021-08
影响因子:
3.8
通讯作者:
Chaudhuri N
中科院分区:
文献类型:
--
作者:
Robey RC;Kemp K;Hayton P;Mudawi D;Wang R;Greaves M;Yioe V;Rivera-Ortega P;Avram C;Chaudhuri N
At the end of the first year of the COVID-19 pandemic, more than 78 million known survivors were recorded. The long-term pulmonary sequelae of COVID-19 remain unknown. We performed a retrospective analysis of a post-COVID follow-up service to estimate the burden of persistent pulmonary morbidity in hospitalised COVID survivors. A total of 221 patients were followed-up: 44 intensive care unit (ICU) and 177 ward patients. Further investigations were planned as per British Thoracic Society Guidelines: For all ICU patients (n = 44) and for 38 of 177 (21%) ward-based patients who had persistent symptoms and/or persistent radiographic changes on CXR at their initial 8-week follow-up visit. In the ward-based cohort, statistically significant associations with persistent symptoms were being an ex- or current smoker, having pre-existing diabetes, and having a longer length of stay. In patients requiring further investigations, pulmonary function tests (PFTs; n = 67) at an average of 15 weeks post-discharge showed abnormalities in at least one PFT parameter in 79% (equating to 24% of the entire cohort). The most common abnormality was an abnormal diffusion capacity of carbon monoxide (TLCO), highest in the ICU cohort (64% ICU vs. 38% non-ICU). TLCO correlated negatively with length of stay and with maximum inspired FiO2 in the patient group as a whole. In ICU patients, TLCO correlated negatively with maximum inspired positive airway pressure. Computed tomography scans (n = 72) at an average of 18 weeks post-discharge showed evidence of persistent ground glass opacities in 44% and fibrosis in 21% (equating to 7% of the entire cohort). Our data add to the growing evidence that there will be pulmonary sequelae in a proportion of COVID survivors, providing some insight into what may become a significant chronic global health problem. The online version contains supplementary material available at 10.1007/s12325-021-01833-4.
登录
查看更多内容
影响因子:
3
作者:
Liu, Kai;Zhang, Weitong;Chen, Ying
通讯作者:
Chen, Ying
DOI:
10.4103/ijri.ijri_469_16
发表时间:
2017-07
期刊:
The Indian journal of radiology & imaging
影响因子:
--
作者:
Das KM;Lee EY;Singh R;Enani MA;Al Dossari K;Van Gorkom K;Larsson SG;Langer RD
通讯作者:
Langer RD
影响因子:
4.3
作者:
Smet J;Stylemans D;Hanon S;Ilsen B;Verbanck S;Vanderhelst E
通讯作者:
Vanderhelst E
影响因子:
5.8
作者:
Huang, Yiying;Tan, Cuiyan;Liu, Jing
通讯作者:
Liu, Jing
影响因子:
9.6
作者:
Hui DS;Wong KT;Ko FW;Tam LS;Chan DP;Woo J;Sung JJ
通讯作者:
Sung JJ